These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12854029)

  • 1. Granulomatous anterior uveitis associated with bimatoprost: a case report.
    Parentin F
    Ocul Immunol Inflamm; 2003 Mar; 11(1):67-71. PubMed ID: 12854029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral nongranulomatous anterior uveitis associated with bimatoprost.
    Packer M; Fine IH; Hoffman RS
    J Cataract Refract Surg; 2003 Nov; 29(11):2242-3. PubMed ID: 14670442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous uveitis and choroidal detachment in a patient after topical treatment with Bimatoprost: A case report.
    Massimo L; Micelli Ferrari L; Nikolopoulou Gisotti E; Zito R; MicelliFerrari T; Anna F; Bordinone MA
    Eur J Ophthalmol; 2022 May; 32(3):NP19-NP22. PubMed ID: 33508974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimatoprost: a novel antiglaucoma agent.
    Woodward DF; Phelps RL; Krauss AH; Weber A; Short B; Chen J; Liang Y; Wheeler LA
    Cardiovasc Drug Rev; 2004; 22(2):103-20. PubMed ID: 15179448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deepening of lid sulcus from topical bimatoprost therapy.
    Peplinski LS; Albiani Smith K
    Optom Vis Sci; 2004 Aug; 81(8):574-7. PubMed ID: 15300114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of bimatoprost.
    Cantor LB
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):151-7. PubMed ID: 16922657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
    Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
    Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
    Sherwood M; Brandt J;
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S361-8. PubMed ID: 11434939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
    Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
    Br J Ophthalmol; 2007 Jun; 91(6):757-60. PubMed ID: 17124241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.
    Krauss AH; Woodward DF
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S5-11. PubMed ID: 15016556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.
    Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Toto L; Mastropasqua L
    Eur J Ophthalmol; 2009; 19(4):594-600. PubMed ID: 19551674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of bimatoprost (Lumigan).
    Woodward DF; Krauss AH; Chen J; Lai RK; Spada CS; Burk RM; Andrews SW; Shi L; Liang Y; Kedzie KM; Chen R; Gil DW; Kharlamb A; Archeampong A; Ling J; Madhu C; Ni J; Rix P; Usansky J; Usansky H; Weber A; Welty D; Yang W; Tang-Liu DD; Garst ME; Brar B; Wheeler LA; Kaplan LJ
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S337-45. PubMed ID: 11434936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystoid macular edema associated with ocular hypotensive lipids.
    Wand M; Gaudio AR
    Am J Ophthalmol; 2002 Mar; 133(3):403-5. PubMed ID: 11860980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
    Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
    Ophthalmologica; 2004; 218(5):312-7. PubMed ID: 15334011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral upper eyelid retraction caused by topical bimatoprost therapy.
    Noma K; Kakizaki H
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):e33-5. PubMed ID: 21562439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM;
    Am J Ophthalmol; 2003 Jan; 135(1):55-63. PubMed ID: 12504698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma.
    Kroll DM; Schuman JS
    Am J Ophthalmol; 2002 Mar; 133(3):401-3. PubMed ID: 11860979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.